Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity
Global diagnostic specialty antibodies market will reach $28.97 billion by 2027, growing by 4.9% annually over 2020-2027 owing to the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the world, the advancements in DNA based technologies and diagnostics, and the increase in the prevalence of diseases such as infectious diseases, influenza and cancer.
Highlighted with 79 tables and 70 figures, this 144-page report “Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire global diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 79 tables and 70 figures, this 144-page report “Global Diagnostic Specialty Antibodies Market 2020-2027 by Type (Monoclonal, Polyclonal, Others), Application (Oncology, Hepatitis, Infectious, Dengue), End User (Hospitals, Diagnostic Labs), and Region: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire global diagnostic specialty antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Types
- Natural/Biological Products
- Synthetic Products
- Oncology Diagnosis
- Hepatitis Diagnosis
- Infectious Disease Diagnosis
- Dengue Diagnostics
- Tuberculosis Diagnostics
- HIV Diagnostics
- Other Applications
- Hospitals & Clinics
- Diagnostic Laboratories
- Other End Users
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- North America (U.S., Canada, and Mexico)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (UAE, Saudi Arabia, South Africa)
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY TYPE
3.1 Market Overview by Type
3.2 Monoclonal Antibodies
3.3 Polyclonal Antibodies
3.4 Other Types
4 SEGMENTATION OF GLOBAL MARKET BY APPLICATION
4.1 Market Overview by Application
4.2 Oncology Diagnosis
4.3 Hepatitis Diagnosis
4.4 Infectious Disease Diagnosis
4.5 Dengue Diagnostics
4.6 Tuberculosis Diagnostics
4.7 HIV Diagnostics
4.8 Other Applications
5 SEGMENTATION OF GLOBAL MARKET BY END USER
5.1 Market Overview by End User
5.2 Hospitals & Clinics
5.3 Diagnostic Laboratories
5.4 Other End Users
6 SEGMENTATION OF GLOBAL MARKET BY REGION
6.1 Geographic Market Overview 2020-2027
6.2 North America Market 2020-2027 by Country
6.2.1 Overview of North America Market
6.2.2 U.S.
6.2.3 Canada
6.2.4 Mexico
6.3 European Market 2020-2027 by Country
6.3.1 Overview of European Market
6.3.2 UK
6.3.3 France
6.3.4 Germany
6.3.5 Spain
6.3.6 Italy
6.3.7 Russia
6.3.8 Rest of European Market
6.4 Asia-Pacific Market 2020-2027 by Country
6.4.1 Overview of Asia-Pacific Market
6.4.2 China
6.4.3 Japan
6.4.4 India
6.4.5 Australia
6.4.6 South Korea
6.4.7 Rest of APAC Region
6.5 South America Market 2020-2027 by Country
6.5.1 Argentina
6.5.2 Brazil
6.5.3 Chile
6.5.4 Rest of South America Market
6.6 MEA Market 2020-2027 by Country
6.6.1 UAE
6.6.2 Saudi Arabia
6.6.3 South Africa
6.6.4 Other National Markets
7 COMPETITIVE LANDSCAPE
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY TYPE
3.1 Market Overview by Type
3.2 Monoclonal Antibodies
3.3 Polyclonal Antibodies
3.4 Other Types
4 SEGMENTATION OF GLOBAL MARKET BY APPLICATION
4.1 Market Overview by Application
4.2 Oncology Diagnosis
4.3 Hepatitis Diagnosis
4.4 Infectious Disease Diagnosis
4.5 Dengue Diagnostics
4.6 Tuberculosis Diagnostics
4.7 HIV Diagnostics
4.8 Other Applications
5 SEGMENTATION OF GLOBAL MARKET BY END USER
5.1 Market Overview by End User
5.2 Hospitals & Clinics
5.3 Diagnostic Laboratories
5.4 Other End Users
6 SEGMENTATION OF GLOBAL MARKET BY REGION
6.1 Geographic Market Overview 2020-2027
6.2 North America Market 2020-2027 by Country
6.2.1 Overview of North America Market
6.2.2 U.S.
6.2.3 Canada
6.2.4 Mexico
6.3 European Market 2020-2027 by Country
6.3.1 Overview of European Market
6.3.2 UK
6.3.3 France
6.3.4 Germany
6.3.5 Spain
6.3.6 Italy
6.3.7 Russia
6.3.8 Rest of European Market
6.4 Asia-Pacific Market 2020-2027 by Country
6.4.1 Overview of Asia-Pacific Market
6.4.2 China
6.4.3 Japan
6.4.4 India
6.4.5 Australia
6.4.6 South Korea
6.4.7 Rest of APAC Region
6.5 South America Market 2020-2027 by Country
6.5.1 Argentina
6.5.2 Brazil
6.5.3 Chile
6.5.4 Rest of South America Market
6.6 MEA Market 2020-2027 by Country
6.6.1 UAE
6.6.2 Saudi Arabia
6.6.3 South Africa
6.6.4 Other National Markets
7 COMPETITIVE LANDSCAPE
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Abbott Laboratories
Abcam plc
Agilent Technologies, Inc.
Aytu BioScience, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Boehringer Ingelheim International GmbH
Creative Diagnostics
Enzo Life Sciences, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Polymun Scientific Immunbiologische Forschung GmbH
Sanofi S.A.
Sartorius AG
Thermo Fisher Scientific Inc.
RELATED REPORTS
LIST OF TABLES
Table 1. Snapshot of Global Diagnostic Specialty Antibodies Market in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Main Product Trends and Market Opportunities in Global Diagnostic Specialty Antibodies Market
Table 4. Global Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 5. Global Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 6. Global Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 7. Global Diagnostic Specialty Antibodies Market by Region, 2017-2027, $ mn
Table 8. Leading National Diagnostic Specialty Antibodies Market, 2020 and 2027, $ mn
Table 9. North America Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 10. U.S. Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 11. U.S. Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 12. U.S. Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 13. Canada Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 14. Canada Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 15. Canada Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 16. Mexico Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 17. Mexico Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 18. Mexico Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 19. Europe Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 20. UK Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 21. UK Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 22. UK Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 23. France Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 24. France Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 25. France Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 26. Germany Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 27. Germany Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 28. Germany Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 29. Spain Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 30. Spain Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 31. Spain Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 32. Italy Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 33. Italy Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 34. Italy Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 35. Russia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 36. Russia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 37. Russia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 38. Diagnostic Specialty Antibodies Market in Rest of Europe by Country, 2017-2027, $ mn
Table 39. APAC Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 40. China Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 41. China Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 42. China Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 43. Japan Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 44. Japan Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 45. Japan Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 46. India Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 47. India Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 48. India Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 49. Australia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 50. Australia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 51. Australia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 52. South Korea Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 53. South Korea Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 54. South Korea Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 55. Diagnostic Specialty Antibodies Market in Rest of APAC by Country/Region, 2017-2027, $ mn
Table 56. South America Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 57. Argentina Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 58. Argentina Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 59. Argentina Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 60. Brazil Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 61. Brazil Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 62. Brazil Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 63. Chile Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 64. Chile Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 65. Chile Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 66. MEA Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 67. UAE Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 68. UAE Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 69. UAE Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 70. Saudi Arabia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 71. Saudi Arabia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 72. Saudi Arabia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 73. South Africa Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 74. South Africa Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 75. South Africa Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 76. Abbott Laboratories: Company Snapshot
Table 77. Abbott Laboratories: Business Segmentation
Table 78. Abbott Laboratories: Product Portfolio
Table 79. Abbott Laboratories: Revenue, 2017-2019, $ mn
Table 1. Snapshot of Global Diagnostic Specialty Antibodies Market in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Main Product Trends and Market Opportunities in Global Diagnostic Specialty Antibodies Market
Table 4. Global Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 5. Global Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 6. Global Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 7. Global Diagnostic Specialty Antibodies Market by Region, 2017-2027, $ mn
Table 8. Leading National Diagnostic Specialty Antibodies Market, 2020 and 2027, $ mn
Table 9. North America Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 10. U.S. Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 11. U.S. Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 12. U.S. Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 13. Canada Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 14. Canada Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 15. Canada Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 16. Mexico Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 17. Mexico Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 18. Mexico Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 19. Europe Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 20. UK Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 21. UK Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 22. UK Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 23. France Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 24. France Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 25. France Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 26. Germany Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 27. Germany Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 28. Germany Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 29. Spain Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 30. Spain Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 31. Spain Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 32. Italy Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 33. Italy Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 34. Italy Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 35. Russia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 36. Russia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 37. Russia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 38. Diagnostic Specialty Antibodies Market in Rest of Europe by Country, 2017-2027, $ mn
Table 39. APAC Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 40. China Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 41. China Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 42. China Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 43. Japan Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 44. Japan Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 45. Japan Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 46. India Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 47. India Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 48. India Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 49. Australia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 50. Australia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 51. Australia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 52. South Korea Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 53. South Korea Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 54. South Korea Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 55. Diagnostic Specialty Antibodies Market in Rest of APAC by Country/Region, 2017-2027, $ mn
Table 56. South America Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 57. Argentina Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 58. Argentina Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 59. Argentina Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 60. Brazil Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 61. Brazil Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 62. Brazil Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 63. Chile Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 64. Chile Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 65. Chile Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 66. MEA Diagnostic Specialty Antibodies Market by Country, 2017-2027, $ mn
Table 67. UAE Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 68. UAE Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 69. UAE Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 70. Saudi Arabia Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 71. Saudi Arabia Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 72. Saudi Arabia Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 73. South Africa Diagnostic Specialty Antibodies Market by Type, 2017-2027, $ mn
Table 74. South Africa Diagnostic Specialty Antibodies Market by Application, 2017-2027, $ mn
Table 75. South Africa Diagnostic Specialty Antibodies Market by End User, 2017-2027, $ mn
Table 76. Abbott Laboratories: Company Snapshot
Table 77. Abbott Laboratories: Business Segmentation
Table 78. Abbott Laboratories: Product Portfolio
Table 79. Abbott Laboratories: Revenue, 2017-2019, $ mn
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 4. Global Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Diagnostic Specialty Antibodies Market
Figure 7. Primary Restraints and Impact Factors of Global Diagnostic Specialty Antibodies Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Global Diagnostic Specialty Antibodies Market
Figure 10. Breakdown of Global Diagnostic Specialty Antibodies Market by Type, 2020-2027, % of Revenue
Figure 11. Contribution to Global 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%)
Figure 12. Global Diagnostic Specialty Antibodies Market: Monoclonal Antibodies, 2017-2027, $ mn
Figure 13. Global Diagnostic Specialty Antibodies Market: Polyclonal Antibodies, 2017-2027, $ mn
Figure 14. Global Diagnostic Specialty Antibodies Market: Other Types, 2017-2027, $ mn
Figure 15. Breakdown of Global Diagnostic Specialty Antibodies Market by Application, 2020-2027, % of Revenue
Figure 16. Contribution to Global 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 17. Global Diagnostic Specialty Antibodies Market: Oncology Diagnosis, 2017-2027, $ mn
Figure 18. Global Diagnostic Specialty Antibodies Market: Hepatitis Diagnosis, 2017-2027, $ mn
Figure 19. Global Diagnostic Specialty Antibodies Market: Infectious Disease Diagnosis, 2017-2027, $ mn
Figure 20. Global Diagnostic Specialty Antibodies Market: Dengue Diagnostics, 2017-2027, $ mn
Figure 21. Global Diagnostic Specialty Antibodies Market: Tuberculosis Diagnostics, 2017-2027, $ mn
Figure 22. Global Diagnostic Specialty Antibodies Market: HIV Diagnostics, 2017-2027, $ mn
Figure 23. Global Diagnostic Specialty Antibodies Market: Other Applications, 2017-2027, $ mn
Figure 24. Breakdown of Global Diagnostic Specialty Antibodies Market by End User, 2020-2027, % of Revenue
Figure 25. Contribution to Global 2021-2027 Cumulative Revenue by End User, Value ($ mn) and Share (%)
Figure 26. Global Diagnostic Specialty Antibodies Market: Hospitals & Clinics, 2017-2027, $ mn
Figure 27. Global Diagnostic Specialty Antibodies Market: Diagnostic Laboratories, 2017-2027, $ mn
Figure 28. Global Diagnostic Specialty Antibodies Market: Other End Users, 2017-2027, $ mn
Figure 29. Global Market Snapshot by Region
Figure 30. Geographic Spread of Worldwide Diagnostic Specialty Antibodies Market, 2020-2027, % of Revenue
Figure 31. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value ($ mn) and Share (%)
Figure 32. North American Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 33. Breakdown of North America Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 34. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 35. U.S. Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 36. Canada Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 37. Diagnostic Specialty Antibodies Market in Mexico, 2017-2027, $ mn
Figure 38. European Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 39. Breakdown of European Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 40. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 41. Diagnostic Specialty Antibodies Market in UK, 2017-2027, $ mn
Figure 42. Diagnostic Specialty Antibodies Market in France, 2017-2027, $ mn
Figure 43. Diagnostic Specialty Antibodies Market in Germany, 2017-2027, $ mn
Figure 44. Diagnostic Specialty Antibodies Market in Spain, 2017-2027, $ mn
Figure 45. Diagnostic Specialty Antibodies Market in Italy, 2017-2027, $ mn
Figure 46. Diagnostic Specialty Antibodies Market in Russia, 2017-2027, $ mn
Figure 47. Diagnostic Specialty Antibodies Market in Rest of Europe, 2017-2027, $ mn
Figure 48. Asia-Pacific Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 49. Breakdown of APAC Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 50. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 51. Diagnostic Specialty Antibodies Market in China, 2017-2027, $ mn
Figure 52. Diagnostic Specialty Antibodies Market in Japan, 2017-2027, $ mn
Figure 53. Diagnostic Specialty Antibodies Market in India, 2017-2027, $ mn
Figure 54. Diagnostic Specialty Antibodies Market in Australia, 2017-2027, $ mn
Figure 55. Diagnostic Specialty Antibodies Market in South Korea, 2017-2027, $ mn
Figure 56. Diagnostic Specialty Antibodies Market in Rest of APAC, 2017-2027, $ mn
Figure 57. South America Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 58. Breakdown of South America Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 59. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 60. Diagnostic Specialty Antibodies Market in Argentina, 2017-2027, $ mn
Figure 61. Diagnostic Specialty Antibodies Market in Brazil, 2017-2027, $ mn
Figure 62. Diagnostic Specialty Antibodies Market in Chile, 2017-2027, $ mn
Figure 63. Diagnostic Specialty Antibodies Market in Rest of South America, 2017-2027, $ mn
Figure 64. Diagnostic Specialty Antibodies Market in Middle East and Africa (MEA), 2017-2027, $ mn
Figure 65. Breakdown of MEA Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 66. Contribution to MEA 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 67. Diagnostic Specialty Antibodies Market in UAE, 2017-2027, $ mn
Figure 68. Diagnostic Specialty Antibodies Market in Saudi Arabia, 2017-2027, $ mn
Figure 69. Diagnostic Specialty Antibodies Market in South Africa, 2017-2027, $ mn
Figure 70. Growth Stage of Global Diagnostic Specialty Antibodies Industry over the Forecast Period
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 4. Global Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Diagnostic Specialty Antibodies Market
Figure 7. Primary Restraints and Impact Factors of Global Diagnostic Specialty Antibodies Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Global Diagnostic Specialty Antibodies Market
Figure 10. Breakdown of Global Diagnostic Specialty Antibodies Market by Type, 2020-2027, % of Revenue
Figure 11. Contribution to Global 2021-2027 Cumulative Revenue by Type, Value ($ mn) and Share (%)
Figure 12. Global Diagnostic Specialty Antibodies Market: Monoclonal Antibodies, 2017-2027, $ mn
Figure 13. Global Diagnostic Specialty Antibodies Market: Polyclonal Antibodies, 2017-2027, $ mn
Figure 14. Global Diagnostic Specialty Antibodies Market: Other Types, 2017-2027, $ mn
Figure 15. Breakdown of Global Diagnostic Specialty Antibodies Market by Application, 2020-2027, % of Revenue
Figure 16. Contribution to Global 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 17. Global Diagnostic Specialty Antibodies Market: Oncology Diagnosis, 2017-2027, $ mn
Figure 18. Global Diagnostic Specialty Antibodies Market: Hepatitis Diagnosis, 2017-2027, $ mn
Figure 19. Global Diagnostic Specialty Antibodies Market: Infectious Disease Diagnosis, 2017-2027, $ mn
Figure 20. Global Diagnostic Specialty Antibodies Market: Dengue Diagnostics, 2017-2027, $ mn
Figure 21. Global Diagnostic Specialty Antibodies Market: Tuberculosis Diagnostics, 2017-2027, $ mn
Figure 22. Global Diagnostic Specialty Antibodies Market: HIV Diagnostics, 2017-2027, $ mn
Figure 23. Global Diagnostic Specialty Antibodies Market: Other Applications, 2017-2027, $ mn
Figure 24. Breakdown of Global Diagnostic Specialty Antibodies Market by End User, 2020-2027, % of Revenue
Figure 25. Contribution to Global 2021-2027 Cumulative Revenue by End User, Value ($ mn) and Share (%)
Figure 26. Global Diagnostic Specialty Antibodies Market: Hospitals & Clinics, 2017-2027, $ mn
Figure 27. Global Diagnostic Specialty Antibodies Market: Diagnostic Laboratories, 2017-2027, $ mn
Figure 28. Global Diagnostic Specialty Antibodies Market: Other End Users, 2017-2027, $ mn
Figure 29. Global Market Snapshot by Region
Figure 30. Geographic Spread of Worldwide Diagnostic Specialty Antibodies Market, 2020-2027, % of Revenue
Figure 31. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value ($ mn) and Share (%)
Figure 32. North American Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 33. Breakdown of North America Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 34. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 35. U.S. Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 36. Canada Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 37. Diagnostic Specialty Antibodies Market in Mexico, 2017-2027, $ mn
Figure 38. European Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 39. Breakdown of European Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 40. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 41. Diagnostic Specialty Antibodies Market in UK, 2017-2027, $ mn
Figure 42. Diagnostic Specialty Antibodies Market in France, 2017-2027, $ mn
Figure 43. Diagnostic Specialty Antibodies Market in Germany, 2017-2027, $ mn
Figure 44. Diagnostic Specialty Antibodies Market in Spain, 2017-2027, $ mn
Figure 45. Diagnostic Specialty Antibodies Market in Italy, 2017-2027, $ mn
Figure 46. Diagnostic Specialty Antibodies Market in Russia, 2017-2027, $ mn
Figure 47. Diagnostic Specialty Antibodies Market in Rest of Europe, 2017-2027, $ mn
Figure 48. Asia-Pacific Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 49. Breakdown of APAC Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 50. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 51. Diagnostic Specialty Antibodies Market in China, 2017-2027, $ mn
Figure 52. Diagnostic Specialty Antibodies Market in Japan, 2017-2027, $ mn
Figure 53. Diagnostic Specialty Antibodies Market in India, 2017-2027, $ mn
Figure 54. Diagnostic Specialty Antibodies Market in Australia, 2017-2027, $ mn
Figure 55. Diagnostic Specialty Antibodies Market in South Korea, 2017-2027, $ mn
Figure 56. Diagnostic Specialty Antibodies Market in Rest of APAC, 2017-2027, $ mn
Figure 57. South America Diagnostic Specialty Antibodies Market, 2017-2027, $ mn
Figure 58. Breakdown of South America Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 59. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 60. Diagnostic Specialty Antibodies Market in Argentina, 2017-2027, $ mn
Figure 61. Diagnostic Specialty Antibodies Market in Brazil, 2017-2027, $ mn
Figure 62. Diagnostic Specialty Antibodies Market in Chile, 2017-2027, $ mn
Figure 63. Diagnostic Specialty Antibodies Market in Rest of South America, 2017-2027, $ mn
Figure 64. Diagnostic Specialty Antibodies Market in Middle East and Africa (MEA), 2017-2027, $ mn
Figure 65. Breakdown of MEA Diagnostic Specialty Antibodies Market by Country, 2020 and 2027, % of Revenue
Figure 66. Contribution to MEA 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 67. Diagnostic Specialty Antibodies Market in UAE, 2017-2027, $ mn
Figure 68. Diagnostic Specialty Antibodies Market in Saudi Arabia, 2017-2027, $ mn
Figure 69. Diagnostic Specialty Antibodies Market in South Africa, 2017-2027, $ mn
Figure 70. Growth Stage of Global Diagnostic Specialty Antibodies Industry over the Forecast Period
